What amount sold does Moleculera Labs, LLC report in Form D filings?

The latest linked filings report $3.4M sold across 3 identified offering(s). 0 unlinked amendment(s) are excluded; 0 offering(s) have no reported amount sold. This is not verified lifetime funding or money raised during a specific period.

When was Moleculera Labs, LLC's most recent SEC filing?

Moleculera Labs, LLC's most recent Form D filing was on 2013-10-18.

How many investors does Moleculera Labs, LLC have?

The most recent Form D filing lists 28 investor(s).

What type of securities does Moleculera Labs, LLC offer?

Moleculera Labs, LLC's SEC Form D filings indicate equity offerings.

Moleculera Labs, LLC

CIK: 0001537411·Biotechnology·Oklahoma City, OK·Corporation·Founded 2012

Reported Sold

$3,382,936

Total Filings

Identified Offerings

Last Filed

Oct 18, 2013

Employees

—

Reported sold uses the latest linked filing for each identified offering; it is not verified lifetime funding. SPV filings are shown separately.

About

Company in Biotechnology industry

SEC EDGAR

Offering filing timeline

Oct 18, 2013Form D — New notice

Reported sold: $2,958,936 · Target: $3,208,936

Rule 506(b)·28 investors

Oct 30, 2012Form D — New notice

Reported sold: $324,000 · Target: $540,000

Rule 506·9 investors

Dec 16, 2011Form D — New notice

Reported sold: $100,000 · Target: $250,000

Rule 506·1 investor

Fundraising Profile

Exemptions

Rule 506(b)

Investors in latest filing

Revenue Range

Decline to Disclose

Reported commissions across identified offerings

Amendment Rate

Latest reported sold across 3 identified offerings

$3,382,936

Uses the latest linked filing for each offering. This is not a measure of money raised in the last year or verified lifetime funding.

Key People

Craig Shimasaki, PhD, MBA

Related Person

Appears on 2 filings

Fred Hiller

Related Person

Appears on 2 filings

David Thomison

Related Person

Appears on 1 filing

Madeleine Cunningham

Related Person

Appears on 1 filing

Filing History

Date	Type	Offering target	Reported sold	Investors
Oct 18, 2013	New	$3,208,936	$2,958,936	28
Oct 30, 2012	New	$540,000	$324,000	9
Dec 16, 2011	New	$250,000	$100,000	1

Filing History

Amendment insights

Loading amendment history…

Comparable issuers

Matched on reported industry and issuer type, then ranked by business location, offering target, and recency. These are filing comparables, not verified business competitors.

Accufy Diagnostics, Inc.

Biotechnology

Offering target: $2,000,000

Filed Oct 28, 2026